...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Bristol Myers buys Myokardia for $13B

Bristol Myers has just spent $13B to buy out MyoKardia because they have a drug for hypertrophic obstructive cardiomyopathy that looks as if it will soon be approved by the FDA. The condition affects about 600,000 Americans. Congestive heart failure affects more than 6 million. How much will that make RVX worth when apabetalone gets approved?

https://www.fiercebiotech.com/biotech/bristol-myers-strikes-13b-myokardia-buyout-to-gain-heart-drug?mkt_tok=eyJpIjoiWm1VM01EaGxPVEF3WmpKaiIsInQiOiJ2NmVSSTBQWm55YzRuam5kNmVUZWJJSjZDdmFRanRVQnRiWVdIcVBLU1lid3dyRlFBeDZsRElTekdMM1RCSGpFSUxYdUY3TzJGalUzZjRVUnJId0lFa3l5b1Z0RTdhME9qS1FUSTFZQjBcL0loOStzM1p2Rkk0Y1p1bmhGS01ZZ0YifQ%3D%3D&mrkid=913011

 

 

Share
New Message
Please login to post a reply